CIP
OGN icon

Convergence Investment Partners’s Organon & Co OGN Stock Holding History

Convergence Investment Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-73,417
Closed -$1.4M – 281
2024
Q3 		$1.4M Buy
73,417
+10,538
+17% +$218K 0.38% 83
2024
Q2 		$1.3M Buy
62,879
+28,805
+85% +$572K 0.38% 76
2024
Q1 		$641K Buy
+34,074
New +$585K 0.25% 114
2023
Q4 		– Sell
-14,888
Closed -$258K – 205
2023
Q3 		$258K Buy
+14,888
New +$310K 0.15% 122

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Convergence Investment Partners's OGN Position: Q4 2024 in Review

Convergence Investment Partners sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 73,417 shares — an estimated $1.4M sold.

Convergence Investment Partners first reported a position in OGN in Q3 2023 and held it in 4 quarters. The position peaked at $1.4M in Q3 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Convergence Investment Partners reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Convergence Investment Partners sold 73,417 Organon & Co shares in Q4 2024, an estimated $1.4M.
  • Convergence Investment Partners first reported a position in Organon & Co in Q3 2023 and held it in 4 quarters.
  • Convergence Investment Partners's Organon & Co position peaked at $1.4M in Q3 2024.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Convergence Investment Partners's 13F filing for Q4 2024, filed 31 Jan 2025.